Abbott Healthcare Products B.V.

🇳🇱Netherlands
Ownership
-
Employees
-
Market Cap
-
Website

Efficacy of Pancrelipase on Postprandial Belching and Bloating.

First Posted Date
2005-12-19
Last Posted Date
2005-12-19
Lead Sponsor
Solvay Pharmaceuticals
Target Recruit Count
45
Registration Number
NCT00266721
Locations
🇺🇸

VAMC, Minneapolis, Minnesota, United States

Analgesic Effectiveness of Three Different Doses of a New Formulation of Lamaline in a Model of Painful Knee (Gonarthrosis)

Phase 3
Completed
Conditions
First Posted Date
2005-12-12
Last Posted Date
2008-02-20
Lead Sponsor
Solvay Pharmaceuticals
Registration Number
NCT00264225
Locations
🇫🇷

Site 3, Andernos Les Bains, France

🇫🇷

Site 105, Angers, France

🇫🇷

Site 101, Angers, France

and more 168 locations

Vasomotoric Symptoms Study of a 0.5 mg Estradiol and 2.5 mg Dydrogesterone Combination

First Posted Date
2005-11-09
Last Posted Date
2008-03-12
Lead Sponsor
Solvay Pharmaceuticals
Target Recruit Count
391
Registration Number
NCT00251082
Locations
🇵🇱

Site 33, Kraków, Poland

🇫🇷

Site 23, Cannes, France

🇫🇷

Site 21, Montpellier, France

and more 15 locations

A Multinational, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Investigate the Efficacy, Safety and Duration of Effect of a Single Administration of Various Doses of Cetrorelix SR in Subjects With Histologically Confirmed Endometriosis

Phase 2
Completed
Conditions
First Posted Date
2005-10-26
Last Posted Date
2008-03-31
Lead Sponsor
Solvay Pharmaceuticals
Registration Number
NCT00244452
Locations
🇷🇴

Site 4007, Bucuresti, Romania

🇷🇴

Site 4005, Bucuresti, Romania

🇺🇦

Site 3803, Kiev, Ukraine

and more 54 locations

Patient-reported Outcomes in the Treatment of Schizophrenia

Phase 3
Completed
Conditions
First Posted Date
2005-10-03
Last Posted Date
2013-09-12
Lead Sponsor
Solvay Pharmaceuticals
Registration Number
NCT00230828

Pharmacokinetic Evaluation of Testosterone Gel (1%)

First Posted Date
2005-09-19
Last Posted Date
2006-12-25
Lead Sponsor
Solvay Pharmaceuticals
Registration Number
NCT00193700
Locations
🇺🇸

Site 209, Cincinnati, Ohio, United States

🇺🇸

Site 205, Seattle, Washington, United States

🇺🇸

Site 207, Brooklyn, New York, United States

and more 6 locations

Bifeprunox in the Treatment of Schizophrenia

Phase 3
Completed
Conditions
First Posted Date
2005-09-19
Last Posted Date
2015-01-16
Lead Sponsor
Solvay Pharmaceuticals
Registration Number
NCT00193713

Bifeprunox in the Treatment of Schizophrenia

Phase 3
Completed
Conditions
First Posted Date
2005-09-19
Last Posted Date
2008-03-24
Lead Sponsor
Solvay Pharmaceuticals
Target Recruit Count
986
Registration Number
NCT00193687

Observation Study of T-Gel (1%) in Treatment of Adolescent Boys With Hypogonadism

First Posted Date
2005-09-19
Last Posted Date
2015-01-16
Lead Sponsor
Solvay Pharmaceuticals
Registration Number
NCT00193661
Locations
🇺🇸

Site 125, Philadelphia, Pennsylvania, United States

🇺🇸

Site 126, Philadelphia, Pennsylvania, United States

🇺🇸

Site 111, Kansas City, Missouri, United States

and more 16 locations

Treatment of Elderly Subjects With Psychosis and Behavioral Disturbances Associated With Dementia of the Alzheimer's Type

First Posted Date
2005-09-12
Last Posted Date
2015-02-09
Lead Sponsor
Solvay Pharmaceuticals
Target Recruit Count
60
Registration Number
NCT00160147
Locations
🇺🇸

Site 910, Santa Ana, California, United States

🇺🇸

Site 902, Carson, California, United States

🇺🇸

Site 911, Pasadena, California, United States

and more 48 locations
© Copyright 2024. All Rights Reserved by MedPath